Your browser doesn't support javascript.
loading
Immune targeting of three independent suppressive pathways (TIGIT, PD-L1, TGFß) provides significant antitumor efficacy in immune checkpoint resistant models.
Franks, S Elizabeth; Fabian, Kellsye P; Santiago-Sánchez, Ginette; Wolfson, Benjamin; Hodge, James W.
Afiliación
  • Franks SE; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Fabian KP; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Santiago-Sánchez G; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Wolfson B; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Hodge JW; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Oncoimmunology ; 11(1): 2124666, 2022.
Article en En | MEDLINE | ID: mdl-36211806

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma / Neoplasias del Colon / Infecciones por Papillomavirus Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Oncoimmunology Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma / Neoplasias del Colon / Infecciones por Papillomavirus Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Oncoimmunology Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos